• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WHO, Netherlands To Hold Fair Drug Pricing Forum In May

27/01/2017 by Intellectual Property Watch 2 Comments

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

The World Health Organization and The Netherlands government will co-host a meeting in the spring that brings experts together to look at high drug prices and government purchasing of medicines.

The forum is planned for the first half of May in The Hague, according to Daniela Bagozzi of the WHO Department of Essential Medicines and Health Products, which is handling the initiative at the WHO.

Details are still being worked out, but it will convene “all of the main stakeholders” involved in negotiations for what medicines governments will purchase, such as governments, industry and others, she told Intellectual Property Watch.

The WHO is aiming to launch a report on pricing at the same time, she said.

The need for the event arises from high-priced medicines that have been seen in developing and developed countries.

Nongovernmental organisations were briefed on the forum yesterday in the margins of this week’s WHO Executive Board meeting.

Intellectual Property Watch will follow with a more in-depth story about the forum soon.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Creative Commons License"WHO, Netherlands To Hold Fair Drug Pricing Forum In May" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP-Watch Briefs, English, Europe, Finance, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

Trackbacks

  1. WHO-Netherlands To Hold Fair Pricing Forum In May – WebLegal says:
    28/01/2017 at 2:33 am

    […] Source: IP Watch The World Health Organization and The Netherlands government will co-host a meeting in the spring that brings experts together to look at high drug prices and the purchasing of medicines. Source: WHO-Netherlands To Hold Fair Pricing Forum In May […]

    Reply
  2. Links 28/1/2017: New Plasma 5 for Slackware, Bodhi Linux 4.1.0 Released | Techrights says:
    29/01/2017 at 1:54 am

    […] WHO-Netherlands To Hold Fair Pricing Forum In May […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.